Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The objective of this study is to evaluate the safety, tolerability, and efficacy of BL-B01D1 in patients with Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors.
Epistemonikos ID: e488af72d3e8abadf99c07bceb4c48868ea669a6
First added on: May 15, 2024